{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:54:53Z","timestamp":1785840893479,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"am","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.pan.2024.08.010","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T17:22:01Z","timestamp":1723569721000},"page":"1133-1140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8476-3985","authenticated-orcid":false,"given":"Hironobu","family":"Suto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Fuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kobara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9559-6182","authenticated-orcid":false,"given":"Keiichi","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2024.08.010_bib1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","article-title":"Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings","volume":"10","author":"Hishinuma","year":"2006","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib2","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer","volume":"27","author":"Iacobuzio-Donahue","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)","volume":"388","author":"Uesaka","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pan.2024.08.010_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial","volume":"389","author":"Neoptolemos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.pan.2024.08.010_bib5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pan.2024.08.010_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jamcollsurg.2015.12.031","article-title":"Adjuvant therapy in pancreas cancer: does it influence patterns of recurrence?","volume":"222","author":"Parikh","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2016.1137","article-title":"Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology trial A021101","volume":"151","author":"Katz","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib9","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1097\/SLA.0000000000004535","article-title":"Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: a phase II open-label multicenter prospective trial (JASPAC05)","volume":"276","author":"Takahashi","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","article-title":"Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial","volume":"5","author":"Murphy","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jjco\/hyy190","article-title":"Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05)","volume":"49","author":"Motoi","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib12","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","article-title":"Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma","volume":"269","author":"Groot","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.surg.2020.04.031","article-title":"Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer","volume":"168","author":"Barnes","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.pan.2024.08.010_bib14","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1200\/JCO.2008.19.7921","article-title":"Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review","volume":"27","author":"Huguet","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22070","volume":"22","author":"Ghaneh","year":"2018","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.pan.2024.08.010_bib16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/jhbp.845","article-title":"Preoperative carbohydrate antigen 19-9 and standard uptake value of positron emission tomography-computed tomography as prognostic markers in patients with pancreatic ductal adenocarcinoma","volume":"29","author":"Moon","year":"2022","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"3","key":"10.1016\/j.pan.2024.08.010_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1634\/theoncologist.2013-0273","article-title":"Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?","volume":"19","author":"Christians","year":"2014","journal-title":"Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.dld.2017.09.122","article-title":"SUVmax after (18)fluoro-deoxyglucose positron emission tomography\/computed tomography: a tool to define treatment strategies in pancreatic cancer","volume":"50","author":"Pergolini","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.pan.2024.08.010_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jso.26854","article-title":"Prediction of local tumour control and recurrence-free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy","volume":"126","author":"Suto","year":"2022","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib21","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1245\/s10434-017-5921-4","article-title":"A\u00a0prospective phase II trial of neoadjuvant S-1 with concurrent hypofractionated radiotherapy in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma","volume":"24","author":"Okano","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MPA.0000000000002011","article-title":"Efficacy and safety of neoadjuvant chemoradiation therapy administered for 5 versus 2 weeks for resectable and borderline resectable pancreatic cancer","volume":"51","author":"Suto","year":"2022","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2024.08.010_bib23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biom J"},{"key":"10.1016\/j.pan.2024.08.010_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12893-019-0644-z","article-title":"The predictors and patterns of the early recurrence of pancreatic ductal adenocarcinoma after pancreatectomy: the influence of pre- and post- operative adjuvant therapy","volume":"19","author":"Suto","year":"2019","journal-title":"BMC Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib25","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1200\/JCO.2005.05.3934","article-title":"Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma","volume":"24","author":"Ferrone","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib26","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1200\/JCO.2008.18.6288","article-title":"Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704","volume":"26","author":"Berger","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib27","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/cncr.24302","article-title":"Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma","volume":"115","author":"Reni","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2024.08.010_bib28","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s11605-009-0916-5","article-title":"Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy?","volume":"13","author":"Turrini","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"Suppl 3","key":"10.1016\/j.pan.2024.08.010_bib29","doi-asserted-by":"crossref","first-page":"S1187","DOI":"10.1245\/s10434-015-4861-0","article-title":"Substaging of lymph node status in resected pancreatic ductal adenocarcinoma has strong prognostic correlations: proposal for a revised N classification for TNM Staging","volume":"22","author":"Basturk","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib30","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s11605-007-0243-7","article-title":"Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer","volume":"11","author":"House","year":"2007","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/his.12732","article-title":"The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy","volume":"68","author":"Fischer","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pan.2024.08.010_bib32","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s11605-017-3544-5","article-title":"Is adjuvant therapy necessary for all patients with localized pancreatic cancer who have received neoadjuvant therapy?","volume":"21","author":"Barnes","year":"2017","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0959-8049(05)80089-9","article-title":"PET scanning in oncology","volume":"28","author":"Wilson","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pan.2024.08.010_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejrad.2009.03.051","article-title":"PET\/CT for the staging and follow-up of patients with malignancies","volume":"70","author":"Poeppel","year":"2009","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.pan.2024.08.010_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.hpb.2023.10.018","volume":"26","author":"Suto","year":"2024","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.pan.2024.08.010_bib36","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jso.25250","article-title":"A\u00a0new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer","volume":"118","author":"Watanabe","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00595-018-1703-2","article-title":"Clinical role of fludeoxyglucose (18F) positron emission tomography\/computed tomography ((18)F-FDG PET\/CT) in patients with pancreatic neuroendocrine tumours","volume":"49","author":"Matsumoto","year":"2019","journal-title":"Surg Today"},{"key":"10.1016\/j.pan.2024.08.010_bib38","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1245\/s10434-017-5799-1","article-title":"Preoperative high maximum standardized uptake value in association with glucose transporter 1 predicts poor prognosis in pancreatic cancer","volume":"24","author":"Chikamoto","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1245\/s10434-014-4046-2","article-title":"Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma","volume":"22","author":"Yamamoto","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jjco\/hyy033","article-title":"18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer","volume":"48","author":"Okano","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.pan.2024.08.010_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002689900215","article-title":"Recurrence after resection for ductal adenocarcinoma of the pancreas","volume":"21","author":"Sperti","year":"1997","journal-title":"World J Surg"},{"key":"10.1016\/j.pan.2024.08.010_bib42","first-page":"1756","article-title":"Pattern of first recurrent lesions in pancreatic cancer: hepatic relapse is associated with dismal prognosis and portal vein invasion","volume":"61","author":"Suenaga","year":"2014","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.pan.2024.08.010_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.semnuclmed.2006.03.005","article-title":"The role of positron emission tomography in the management of pancreatic cancer","volume":"36","author":"Pakzad","year":"2006","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.pan.2024.08.010_bib44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ijrobp.2013.09.005","article-title":"Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design","volume":"87","author":"Dholakia","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.pan.2024.08.010_bib45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11605-008-0762-x","article-title":"Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio","volume":"13","author":"Asiyanbola","year":"2009","journal-title":"J\u00a0Gastrointest Surg"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390324007075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390324007075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T15:35:18Z","timestamp":1731166518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390324007075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1424390324007075"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2024.08.010","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2024.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}